LEXAGENE HOLDINGS INC (LXG.CA) Stock Price & Overview
TSX-V:LXG • CA52886L1031
The current stock price of LXG.CA is 0.105 CAD. Today LXG.CA is down by -19.23%. In the past month the price decreased by -62.5%. In the past year, price decreased by -63.16%.
LXG.CA Key Statistics
- Market Cap
- 14.767M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.18
- Dividend Yield
- N/A
LXG.CA Stock Performance
LXG.CA Stock Chart
LXG.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to LXG.CA. When comparing the yearly performance of all stocks, LXG.CA is a bad performer in the overall market: 97.7% of all stocks are doing better.
LXG.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LXG.CA. Both the profitability and financial health of LXG.CA have multiple concerns.
LXG.CA Earnings
LXG.CA Forecast & Estimates
9 analysts have analysed LXG.CA and the average price target is 0.51 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.105.
LXG.CA Groups
Sector & Classification
LXG.CA Financial Highlights
Over the last trailing twelve months LXG.CA reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -45.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.44 |
LXG.CA Ownership
LXG.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 256.57M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 68.121M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 61.626M | ||
| MIR | MEDMIRA INC | N/A | 45.499M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 43.436M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 21.548M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 20.768M | ||
| ASG | AURORA SPINE CORP | N/A | 20.077M | ||
| MDX | MEDX HEALTH CORP | N/A | 16.397M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.693M | ||
| VVTM | VVT MED INC | N/A |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About LXG.CA
Company Profile
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.
Company Info
IPO: 2007-08-28
LEXAGENE HOLDINGS INC
500 Cummings Ctr., Suite 4550
Beverly MASSACHUSETTS 01915 US
CEO: John F. Regan
Employees: 33
Phone: 18002151824.0
LEXAGENE HOLDINGS INC / LXG.CA FAQ
What does LXG do?
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.
What is the stock price of LEXAGENE HOLDINGS INC today?
The current stock price of LXG.CA is 0.105 CAD. The price decreased by -19.23% in the last trading session.
What is the dividend status of LEXAGENE HOLDINGS INC?
LXG.CA does not pay a dividend.
What is the ChartMill rating of LEXAGENE HOLDINGS INC stock?
LXG.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for LXG stock?
LEXAGENE HOLDINGS INC (LXG.CA) currently has 33 employees.
What is LEXAGENE HOLDINGS INC worth?
LEXAGENE HOLDINGS INC (LXG.CA) has a market capitalization of 14.77M CAD. This makes LXG.CA a Nano Cap stock.